L
LeChauncy D. Woodard
Researcher at Baylor College of Medicine
Publications - 53
Citations - 1552
LeChauncy D. Woodard is an academic researcher from Baylor College of Medicine. The author has contributed to research in topics: Health care & Medicine. The author has an hindex of 14, co-authored 40 publications receiving 1398 citations. Previous affiliations of LeChauncy D. Woodard include Veterans Health Administration & Health Science University.
Papers
More filters
Journal ArticleDOI
Does Pay-for-Performance Improve the Quality of Health Care?
TL;DR: A systematic search of the English-language literature in PubMed was conducted to find articles published between 1 January 1980 and 14 November 2005 whose main objective was to assess the use of explicit financial incentives to improve health care quality.
Journal ArticleDOI
Gender Disparities in Evidence-Based Statin Therapy in Patients With Cardiovascular Disease
Salim S. Virani,LeChauncy D. Woodard,David Ramsey,Tracy H. Urech,Julia M. Akeroyd,Tina Shah,Tina Shah,Anita Deswal,Anita Deswal,Biykem Bozkurt,Biykem Bozkurt,Christie M. Ballantyne,Christie M. Ballantyne,Laura A. Petersen +13 more
TL;DR: This article showed gender disparities in cholesterol care in patients with cardiovascular disease (CVD), with women less likely than men to have low-density lipoprotein cholesterol levels, while men were more likely to have high cholesterol levels.
Journal ArticleDOI
Impact of comorbidity type on measures of quality for diabetes care.
TL;DR: Patients with the greatest clinical complexity were more likely than less complex patients to receive high quality diabetes care, suggesting that increased complexity does not necessarily predispose chronically ill patients to receiving poorer care.
Journal ArticleDOI
Is High‐Intensity Statin Therapy Associated With Lower Statin Adherence Compared With Low‐ to Moderate‐Intensity Statin Therapy? Implications of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guidelines
Salim S. Virani,LeChauncy D. Woodard,Julia M. Akeroyd,David Ramsey,Christie M. Ballantyne,Christie M. Ballantyne,Laura A. Petersen +6 more
TL;DR: The recent cholesterol guideline recommends high‐intensity statins in cardiovascular disease (CVD) patients, and it may be of concern that these recommendations might reduce statin adherence.
Journal ArticleDOI
Frequency and correlates of treatment intensification for elevated cholesterol levels in patients with cardiovascular disease
Salim S. Virani,LeChauncy D. Woodard,LeChauncy D. Woodard,Supicha S. Chitwood,Supicha S. Chitwood,Cassie R. Landrum,Cassie R. Landrum,Tracy H. Urech,Tracy H. Urech,Degang Wang,Degang Wang,Jeffrey Murawsky,Christie M. Ballantyne,Christie M. Ballantyne,Laura A. Petersen,Laura A. Petersen +15 more
TL;DR: Diabetic and hypertensive patients were more likely to receiving treatment intensification, whereas, older patients, female patients, and patients with poor medication adherence were less likely to receive treatment intensifying.